Abstract
Background and Aims: Left ventricular assist device (LVAD) patients are at increased risk of thrombo-embolisms and major bleedings, making anticoagulation therapy challenging. Unstable anticoagulant control expressed as high international normalized ratio (INR) variability, is associated with clinical events in atrial fibrillation patients. However, data on this association in LVAD patients are unavailable. We therefore aimed to study the association between anticoagulant control and clinical events in patients with an LVAD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
